Grade C4.2/10Zamazenta (#201) from Destined Rivals currently trades at €2.99 in the raw market. Over the past 30 days the card has declined -3.7%. By market value it ranks #49 of 244 in Destined Rivals — the 80th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated high. Read together, a upper-tier ranking in Destined Rivals alongside softening 30-day momentum frames where Zamazenta sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.
€2.99 (raw, market average).
It ranks #49 of 244 cards by market value, in the 80th percentile of the set.
It has declined -3.7% over the past 30 days.
60 raw-NM sales tracked over the trailing 180 days.